Recent Report on PotNetwork Holding Inc. (POTN) Share Price Target Highlights Encouraging Data

  • Heightened share price target for PotNetwork Holding Inc. set at $1.25
  • Previous market estimates, exceeded by over 70 percent, show positive month-to-month sales for PotNetwork Holdings Inc.
  • SeeThruEquity report highlights the greatly lowered legal and physiological risk from hemp-derived CBD

A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a heightened share price target set at $1.25. The increase was attributed to the company’s strong monthly sales data and 3Q17 filings (http://cnw.fm/A2krk). Per the report, these indicated “continued profitability as the company invests in growth.”

In a prior news release, Dr. Richard Goulding, CEO of PotNetwork Holding Inc., stated, “It is very rewarding to experience this type of growth and success, and all the more pleasing to see an acknowledgement of our collective efforts in the marketplace.”  This statement followed news that the company’s previously announced estimates of $8.3 million were exceeded by over 70 percent, reaching $14.5 million due to rapid month-to-month growth in sales (http://cnw.fm/Rt1p8).

SeeThruEquity’s report highlighted that hemp derived from CBD can provide a legal alternative to marijuana-based CBD, which is banned by federal law. This allows consumers to make use of CBD products without the risk of experiencing a ‘high’ or infringing on government law. The projected market for hemp-derived CBD is expected to grow at a CAGR of roughly 53 percent through 2020, positioning it among the fastest-growing segments within the multi-billion dollar legal cannabis and hemp market.

Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the most researched derivatives of cannabis, a psychoactive drug also known as marijuana (http://cnw.fm/u83jV).  The traditional ‘high’ associated with this drug is largely thanks to the presence of THC, and, while CBD is a structural isomer of THC (meaning that it has the same chemical composition), the atomic structure is arranged differently, offering many of the same health benefits without the psychoactive effects of THC. Based on numerous studies, CBD has demonstrated the capacity to produce a number of effects on the endocannabinoid system (ECS), including boosting immune system function, reducing sensations of pain, playing a role in inflammatory response and altering appetite, mood, memory and energy levels.

With the advancement of technology and ongoing research of the medicinal qualities of CBD, it is possible that these products could, potentially, serve as substitutes for harmful medications that are currently on the market.  The natural healing properties are being assessed on a global level, and several journals have already noted the economic impact of CBD in general. Matt Karnes of Greenwave Advisors, in an interview with Forbes, stated, “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only — this is in addition to the 28 states plus DC that have legalized medical marijuana.”

Numerous studies on the positive effects of cannabinoids and THC have paved the way for legalization of marijuana for medicinal purposes in Canada and the U.S.  A focus report by Mackie Research Capital Corp. (http://cnw.fm/Dgh2g) notes that (based on internal models) the Canadian marijuana market is expected to increase in size quickly, with the forecast peak in market size to exceed C$2.5 billion by 2020. With the United States presenting various states in which medicinal marijuana is legal, the market size for these states (most notably Colorado, Arizona, Oregon and Michigan) is projected to record a significant increase in growth from 2015 to 2020. For the above-mentioned states, the Colorado market is expected to reach more than $1.5 billion, Arizona is expected to exceed $453 million, Oregon could increase to $330 million and Michigan is expected to rise to $556 million, all by 2020.

PotNetwork Holding Inc. is a publicly traded company that acts as a holding company for a number of subsidiaries, namely First Capital Venture Co., PotNetwork.com, and Diamond CBD, Inc.  The latter focuses on research, development and multinational marketing of hemp extracts containing a wide variety of cannabinoids and natural hemp derivatives.  Diamond CBD’s team of hemp industry pioneers, chemists, doctors, scientists and natural product experts aims to produce high-grade CBD oil, providing a variety of CBD oils, tinctures, edibles and vape liquids.

In a previous news release (http://cnw.fm/6q5VV), Goulding added, “[W]e are proud, and think our shareholders should be too, that on December 13, 2017 PotNetwork Holding was named by Huffington Post, a prominent major national news source, as “One of Five Notable CBD Revolution Industry Leaders’, an accolade that pays tribute to the company’s achievements and future prospects.”

Goulding further noted, “2017 has been a phenomenally successful year for us! Our unprecedented sales growth pays tribute to the hard work of our staff and our resellers, and the exceptional quality of our CBD product line which expanded greatly over 2017.” He also emphasized that the company is poised for growth during 2018 and it embarks on new and unique marketing initiatives and embraces new opportunities.

Without question, the recent report by SeeThruEquity highlighting PotNetwork Holding Inc. and Diamond CBD projects not only an increased share price target, but also a positive expansion of the company within this multi-billion dollar arena.  With an ever-increasing demand for safer products of this nature that abide by all governing regulations, PotNetwork Holding Inc., also with its subsidiaries, has its foot in the door of tomorrow’s market.

For more information, visit the company’s website at www.PotNetworkHolding.com

Pursuant to the applicable federal law, the sale or distribution of CBD with less than 0.03% of tetrahydrocannabinol by retailers may be permissible in all states.  However, the local, state and federal laws regarding these issues tend to remain in flux and should be accordingly reviewed by local counsel and, as such, legal advice is not intended, but specifically disclaimed.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s